Allergen modification of the ovalbumin as possible method to minimize the egg allergenic reaction into the human organism and its inclusion in a food product
Abstract
The production strategy for enhanced ovalbumin protein was realized based on the allergenic properties described in the previous delivery. As a production agency
Pichia Pastoris was established which is a highly used eukaryotic organism for the mass production of proteins and
pPIC9K was chosen as the cloning vector of the sequence to be synthesized. For the protein production strategy, the computer tools available on the web;
sequence Manipulation Suite (
www.bioinformatics.org) were used for reverse translation of the protein;
Codon Usage Database (
www.kazusa.or.jp) for the most likely codon usage table in
Pichia Pastoris;
EMBL (
www.embl.de) for vector selection of interest;
SnapGene (
www.snapgene.com) as a search repository for plasmid mapping and
Benchling (
www.benchling.com) for the gene cloning process to be synthesized with the optimized codon sequence for our ovalbumin protein.